Skretting and Proteon to trial bacteriophages for aquaculture

  30 January 2021

Skretting and Proteon Pharmaceuticals are co-developing products using bacteriophages to support fish farmers as part of a holistic health strategy.

The companies will work in a parallel R&D pipeline for the project to target pathogenic bacteria. With bacterial challenges being some of the most prevalent in aquaculture worldwide, the products will be a welcome addition to the holistic health toolbox for farmers.

 

Further reading: The Fish Site
Author(s): The Fish Site
Healthy Animals   Secure Foods  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed